2006 Volume 24 Pages 79-85
Since July 1994, we have used microwave coagulo-necrotic therapy (MCN) for patients with hepatocellular carcinoma (HCC) in our institute. All our new patients were classified by prognostic staging system (CLIP score, JIS score, modified JIS score and Tokyo Score) and those survival rate were assessed.
In each staging score, the cumulative survival rates in MCN group were almost equal to those in hepatic resection (Hr) group.
Based on the above, it was suggested that MCN has the ability of loco-regional control of HCC and MCN can be a first choice for the treatment of HCC.
